Literature DB >> 35103228

Multiple Audiometric Analysis in the Screening of Vestibular Schwannoma.

Erika Celis-Aguilar1, Alejandra Obeso-Pereda1, Karla M Castro-Bórquez1, Edgar Dehesa-Lopez2, Alfredo Vega-Alarcon3, Heloisa Coutinho-De Toledo4.   

Abstract

Introduction Asymmetric sensorineural hearing loss is the main early symptom of retrocochlear lesions, hence its importance in screening for vestibular schwannomas. Currently, there is no consensus regarding its definition. The objective was to identify the audiometric pattern that would serve as a predictor for vestibular schwannoma in patients with asymmetric hearing loss. Materials and methods A cross-sectional study was conducted that included patients with asymmetric hearing loss attending a secondary care center and a tertiary care center. Clinical, audiometric and imaging (MRI with gadolinium) variables were collected. Asymmetric hearing loss was defined as a difference of 15 dB in one or more frequencies between both ears. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of different audiometric patterns were analyzed. Results A total of 107 patients were studied and divided into two groups: group 1 without vestibular schwannoma (n=98); and group 2 with vestibular schwannoma (n=9). No significant difference in demographic characteristics or audiometric patterns was found in patients with and without vestibular schwannoma. The audiometric pattern with the best sensitivity as a screening test was a difference >20 dB in the 4,000 Hz frequency, with a sensitivity of 77.78%, specificity of 30.61%, PPV of 8.33%, NPV of 93.75% and accuracy of 34.50%. Conclusion The audiometric pattern with the best results was a difference >20 dB in the 4,000 Hz frequency range; however, patients with asymmetric hearing loss could not be differentiated from patients with retrocochlear lesions based only on audiometry. Asymmetrical hearing loss must be studied with MRI.
Copyright © 2022, Celis-Aguilar et al.

Entities:  

Keywords:  acoustic neuroma; asymmetric hearing loss; audiometry; diagnostic tests; retrocochlear diseases; sensorineural hearing loss; vestibular schwannoma

Year:  2022        PMID: 35103228      PMCID: PMC8783613          DOI: 10.7759/cureus.21492

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

Asymmetric hearing loss is a difference in hearing loss between both ears, in which the contralateral ear might also be affected. Although hearing loss is the third most frequent cause of disability in some countries [1], there is currently no consensus regarding the definition of asymmetric hearing loss. Unfortunately, this lack of a standard definition makes the asymmetric hearing loss a controversial topic and this is aggravated by multiple definitions that have been previously published [2-15]. Furthermore, simple audiometry could be a potential early indicator of vestibular schwannoma (VS), becoming a simple and cost-effective tool for the screening of these tumors. It is estimated that 2%-8% of patients with asymmetric hearing loss have retrocochlear lesions [15], this symptom could represent an early symptom, hence its importance in screening for VSs. Asymmetric sensorineural hearing loss can be caused by damage to the cochlear hair cells, retrocochlear lesions and even cortical hearing loss. Additionally, we should consider cochlear nerve disease such as that produced by pontocerebellar angle lesions which can include meningiomas, petrous apex cholesteatomas, multiple sclerosis and, more commonly, VSs; this latter pathology causes mechanical compression of the cochlear nerve [16]. The incidence of VSs in the general population is 10 to 15 cases per million inhabitants per year [17,18]. VSs or acoustic neurinomas are benign, slow-growing tumors arising from the eighth cranial nerve. They are the most common tumors of the pontocerebellar angle and represent 6%-10% of intracranial tumors [10]. Actually, the main symptom of VS is sensorineural hearing loss which is usually asymmetric, gradual and high-tone hearing loss with greater asymmetry in the frequency range of 2-8 kHz [18]. The mechanism by which a VS causes hearing loss may not be attributed only to its size but are related to biomarkers, such as perilymph proteins and other specific subtypes of heat shock protein 70 (HSP70) [19]. Approximately 50% to 60% of VSs lead to gradual or abrupt hearing loss at high frequencies, with only 4% to 26% of patients presenting sudden hearing loss [20]. Gadolinium-enhanced nuclear magnetic resonance imaging (MRI) is the current diagnostic gold standard for retrocochlear lesions [5,21]. However, because the number of MRI exams needed on this group of patients is very large, and the number of schwannomas found is very small, screening algorithms have been developed to preserve and maximize resources [22]. The ideal screening test should be accurate and inexpensive, but to date, such a test does not exist in the initial diagnosis of schwannomas [23]. However, it is necessary to balance the possibility of not diagnosing pontocerebellar angle tumors vs. cost savings. Currently, there are multiple audiometric patterns described in the literature, reported to have sensitivities ranging from 88% to 90% and specificities from 30% to 57% [10,15,24]. Some diagnostic algorithms have also been described, combining the patient’s history and clinical symptoms with audiometric changes. In our study, we sought to determine the audiometric pattern to be used as a screening test for VS.

Materials and methods

The study design was a cross-sectional study. The location was multicenter. Consecutive patients were included from March 2009 to December 2010 at a tertiary care center and April 2016 to August 2018 at a secondary care center in a single otolaryngology clinic. Subjects The inclusion criteria were patients who attended the otorhinolaryngology service of a secondary care center and a tertiary care center with a diagnosis of asymmetric hearing loss by audiometry, defined as a difference of 15 dB in one or more frequencies between ears. After a diagnosis of asymmetric hearing loss, MRI was indicated. Only patients with MRI examinations were included. The exclusion criteria were patients who did not consent to participate, patients with hearing loss of conductive origin, patients with retrocochlear lesions other than VSs, and patients with previous pontocerebellar angle surgery. The elimination criteria were patients who had an incomplete audiometric study and/or absence of MRI. Data on age, sex, tinnitus, vertigo, exposure to ototoxic drugs, trauma, ear surgery, noise exposure, stapedial reflexes, evoked potentials, MRI, otoacoustic emissions, and asymmetric hearing loss were collected. Once the diagnosis of MRI was obtained, patients were ultimately compared and categorized into two groups: group 1 without VS (WOVS) and group 2 with VS (WVS). Clinical and demographic characteristics were described for Group 1 (WOVS) and Group 2 (WVS). Definition of hearing loss This study analyzed all possible definitions of asymmetric hearing loss and the most inclusive definition was chosen: a difference of 15 dB in one or more frequencies between ears. All definitions available in the literature of asymmetric hearing loss were analyzed [2-15]. Calculations of each of these definitions were carried out for each patient. Also, a definition was added, which consisted of a ≥15 dB asymmetry at 4,000 Hz ( Modified 4000 Rule). Statistical analysis The data were analyzed with the SPSS statistical package, version 21.0 (SPSS, Chicago, IL, USA). Descriptive statistics were used with measures of central tendency and dispersion according to the distribution of the data. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio, negative likelihood ratio and accuracy were calculated. The data were compared using the χ2 test for categorical variables and Student’s t-test for continuous variables. The definitions of asymmetric hearing loss described in the literature [2-15], were categorized as present or absent on each patient, and contingency tables were created for the calculation of diagnostic tests (sensitivity, specificity, PPV, NPV, accuracy). A receiver operator characteristic (ROC) curve was obtained to choose the best diagnostic test. Ethical approval was obtained from the Research Committee at our institution (Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suarez, no number assigned), informed consent was signed by all patients.

Results

A total of 107 patients were included; 1 patient was excluded due to meningioma. Thus, 107 patients were ultimately included: group 1, without VS (WOVS) n=98 (91.6%) and group 2, with nine patients with VS (WVS) (8.4%). Basal demographic characteristics were collected (Table 1) and analyzed without finding significant differences between the two groups. The mean age was 47.94±14.14 years old, and 68.2% (n=73) were women. The more frequently affected ear was the left ear in 54.2% (n=58), and the most frequently observed type of hearing loss was gradual hearing loss in 69.2% (n=74) of the cases. The mean age of group 1 (WOVS) was 47.86±14.1 years old, and the mean age of group 2 (WVS) was 48.89 ± 14.4 years old (p=0.145).
Table 1

Demographic characteristics of the population

WOVS: Without Vestibular Schwannoma, WVS: With Vestibular Schwannoma.

  Demographic characteristics Groups   p
WOVS.                               WVS.
n %                                n %
Sex Female 68 69.4 5 55.6 0.394
Male 30 30.6 4 44.4
Affected ear Right 47 48.0 2 22.2 0.138
Left 51 52.0 7 77.8
Type of hearing loss Progressive 66 68.8 8 88.9 0.205
Sudden 30 31.3   1 11.1
Time of progress in months (mean, standard deviation) 45.35 ± 91.66          47.11 ± 46.55 0.644
Headache Negative 78 79.6   8 88.9 0.502
Positive 20 20.4 1 11.1
Tinnitus Negative 5 5.2 0 0 0.485
Positive 92 94.8 9 100
Tinnitus side Right 36 39.1 2 22.2 0.322
Left 43 46.7 7 77.8
Bilateral 3 3.3 0 0
Vertigo Negative 34 34.7 5 55.6 0.213
Positive 64 65.3 4 44.4
Unsteadiness Negative 34 34.7 2 22.2 0.449
Positive 64 65.3 7 77.8
Noise exposure Negative 78 86.7 8 88.9 0.945
Positive 11 12.2 1 8.3
Ototoxic Drugs Negative 78 85.7 9 100 0.478
Positive 11 12.1 0 0
Family history Negative 80 83.3 7 77.8 0.672
Positive 16 16.7 2 22.2
Trauma Negative 88 89.8 8 88.9 0.932
Positive 10 10.2 1 11.1
Otoscopy Normal 92 93.9 9 100 0.445
Abnormal 6 6.1 0 0
Facial movement Normal 88 89.8 8 88.9 0.932
Abnormal 10 10.2 1 11.1
Electronystagmography Normal 21 32.3 1 11.1 0.192
(n=74) Abnormal 44 67.7 8 89.9  
Otoacoustic emissions (n=12) Normal 1 9.1 0 0 0.735
  Abnormal 10 90.9 1 100  
Brains stem auditory evoked potentials (ABR) (n=20) Normal 19 100 0 0 <0.0001
  Abnormal 0 0 1 100  
Stapedius reflex (n=105) Normal 59 60.8 3 37.5 0.197
  Abnormal 38 39.2 5 62.5  

Demographic characteristics of the population

WOVS: Without Vestibular Schwannoma, WVS: With Vestibular Schwannoma. In our study, we observed that the left ear was more frequently affected in both groups (group 1=52.0% vs. group 2=77.8%; p=0.1). Progressive hearing loss was also a prevalent clinical feature in both groups (88.9% vs. 68.8%; p=0.2). The duration of hearing loss progression was 45.3 in group 1 vs. 47.11 months in group 2 (p=0.644). The absence of vertigo was 55.6% vs. 34.7%; (p=0.21), respectively. Tinnitus was present in most patients, documented in 94.8% (n=92) of group 1 and 100% (n=9) of group 2, with no significant difference between the groups (p=0.45). However, 100% of the patients with bilateral tinnitus belonged to group 1. The causes of facial mobility disorders observed in group 1 (WOVS) were as follows: Bell’s facial paralysis (n=6), recurrent facial paralysis (n=1), Melkersson-Rosenthal syndrome (n=1), demyelinating disease (n=1) and idiopathic (n=1). The only case of facial mobility disorder documented in group 2 (WVS) occurred in a patient with schwannoma and a history of facial paralysis one year prior to diagnosis. An abnormal otoscopy was documented in 6 cases, in order of frequency: due to myringosclerosis (n=2), opaque membrane (n=2), tympanic graft (n=1) and an external auditory canal osteoma (n=1). As part of their diagnostic protocol, some patients underwent neuro-otological tests, the results of which were not significantly different between the two groups, except for auditory brainstem response (p ≤ 0.001), nevertheless the sample is small (Table 1). The mean threshold in every frequency between both ears was analyzed, as well as the mean asymmetries of sensorineural hearing loss are represented in Table 2. None of the mean asymmetries of sensorineural hearing were significant (Table 2).
Table 2

Mean hearing thresholds and MASNHL

Results are represented by mean ± standard deviation. WOVS: Without Vestibular Schwannoma, WVS: With Vestibular Schwannoma, MHT: Mean hearing thresholds, MASNHL: Mean Asymmetries of Sensorineural Hearing Loss

*Difference between mean hearing thresholds of the affected ear and best ear

FrequenciesWOVSWVSWOVSWVSp
MHT of affected ear (dB)MHT of best ear (dB)MHT of affected ear (dB)MHT of best ear (dB)MASNHL (dB)*MASNHL (dB)*
150 Hz50.26 ± 29.5817.22 ± 12.7733.89 ± 21.0317.22 ± 12.7732.65 ± 30.6016.66 ± 19.200.128
250 Hz52.96  ±29.1816.53  ± 10.7040.00  ± 29.6816.11  ± 9.9336.42 ± 29.3923.88 ± 27.010.221
500 Hz56.07 ± 30.4614.90 ± 9.7340.56 ± 28.9817.22 ± 10.3441.17 ± 30.7423.33 ± 23.840.094
1,000 Hz56.48 ± 30.8715.46 ± 10.8457.22 ± 44.3712.78 ± 9.7141.12 ± 31.4444.44 ± 43.400.770
2,000 Hz54.74 ± 30.9516.33 ± 12.8565.56 ± 49.6514.44 ± 12.1038.41 ± 31.1151.11 ± 52.360.275
4,000 Hz60.66 ± 31.4323.57 ± 17.1476.67 ± 46.9025.00 ± 17.3237.19 ± 30.7551.66 ± 44.150.197
8,000 Hz71.30 ± 30.0830.41 ± 22.4984.44 ± 39.9527.22 ± 25.1339.43 ± 32.6357.22 ± 49.440.139

Mean hearing thresholds and MASNHL

Results are represented by mean ± standard deviation. WOVS: Without Vestibular Schwannoma, WVS: With Vestibular Schwannoma, MHT: Mean hearing thresholds, MASNHL: Mean Asymmetries of Sensorineural Hearing Loss *Difference between mean hearing thresholds of the affected ear and best ear The audiometric assessments performed in both groups were analyzed based on the audiometric patterns previously described in the literature, and no significant differences were found in any pattern (Table 3).
Table 3

Asymmetry analysis according to the different definitions in the literature

*: Analysis accomplished by using the frequency 4,000 Hz instead of 3,000 Hz.

Modified Rule 4000 (¥):≥15 dB asymmetry at 4,000 Hz.

AAO-HNS: American Academy of Otolaryngology-Head and Neck Surgery

AMCLASS - Audiogram Classification System - (&): ≥10 dB at any two neighboring frequencies

Obholzer (A): ≥15 dB in two neighboring frequencies if better ear averaging 250 to 8,000 Hz is <30 dB.

Obholzer (B): ≥20 dB in two neighboring frequencies if better ear averaging 250 to 8,000 Hz is >30 dB.

AsymmetryGroup 1 (WOVS)Group 2 (WSV)p
n%n%
UK Department of Health8384.7777.80.587
Sunderland                                   7273.5555.60.252
AAO-HNS*7475.5666.70.599
Oxford7677.6666.70.460
Seattle7576.5666.70.509
Nashville8990.8777.80.218
AMCLASS (&)8384.7777.80.587
Modified Rule 4000¥7778.6777.80.956
Rule 40006869.4777.80.599
Cueva8879.6777.80.897
Mangham8283.7777.80.651
Schlauch y Levine6768.4555.60.433
Sheppard7576.5666.70.509
Obholzer (A)6970.4666.70.815
Obholzer (B)3131.6555.60.146

Asymmetry analysis according to the different definitions in the literature

*: Analysis accomplished by using the frequency 4,000 Hz instead of 3,000 Hz. Modified Rule 4000 (¥):≥15 dB asymmetry at 4,000 Hz. AAO-HNS: American Academy of Otolaryngology-Head and Neck Surgery AMCLASS - Audiogram Classification System - (&): ≥10 dB at any two neighboring frequencies Obholzer (A): ≥15 dB in two neighboring frequencies if better ear averaging 250 to 8,000 Hz is <30 dB. Obholzer (B): ≥20 dB in two neighboring frequencies if better ear averaging 250 to 8,000 Hz is >30 dB. The sensitivity and specificity of each audiometric pattern were measured, finding seven audiometric patterns with sensitivity of 77.78% (Table 4). The highest specificity was at a difference >20 dB in two adjacent frequencies if the average at 250 to 8,000 Hz was >30 dB in the better ear.
Table 4

Sensitivity and specificity analysis

S: Sensitivity, SPE: Specificity, PPV: Positive predictive value, NPV: Negative predictive value, PLR: Positive likelihood ratio, NLR: Negative Likelihood ratio

*: Analysis accomplished by using the frequency 4,000 Hz instead of 3,000 Hz

Modified Rule 4000 (¥):≥15 dB asymmetry at 4,000 Hz

AAO-HNS: American Academy of Otolaryngology-Head and Neck Surgery

AMCLASS - Audiogram Classification System - (&): ≥10 dB at any two neighboring frequencies

Obholzer (A): ≥15 dB in two neighboring frequencies if better ear averaging 250 to 8,000 Hz is <30 dB. Obholzer (B): ≥20 dB in two neighboring frequencies if better ear averaging 250 to 8,000 Hz is >30 dB.

Type of AsymmetrySSPEPPVNPVPLRNLRAccuracy
UK Department of health77.78%15.31%7.78%88.24%0.921.4520.56%
Sunderland55.56%26.53%6.49%86.67%0.761.6828.97%
AAO-HNS*66.67%24.49%7.50%88.89%0.881.3628.04%
Oxford66.67%22.45%7.32%88.00%0.861.4826.17%
Seattle66.67%23.47%7.41%88.46%0.871.4227.10%
Nashville77.78%9.18%7.29%81.82%0.862.4214.95%
AMCLASS (&)77.78%15.31%7.78%88.24%0.921.4520.56%
Modified Rule of 4000(¥)77.78%21.43%8.33%91.30%0.991.0426.17%
Rule 400077.78%30.61%9.33%93.75%1.120.7334.58%
Cueva77.78%20.41%8.24%90.91%0.981.0925.23%
Mangham77.78%16.33%7.87%88.89%0.931.3621.50%
Schlauch y Levine55.56%31.63%6.94%88.57%0.811.4133.64%
Sheppard66.67%23.47%7.41%88.46%0.871.4227.10%
Obholzer (A)66.67%29.59%8.00%90.62%0.951.1332.71%
Obholzer (B)55.56%68.37%8.41%94.37%1.760.6567.29%

Sensitivity and specificity analysis

S: Sensitivity, SPE: Specificity, PPV: Positive predictive value, NPV: Negative predictive value, PLR: Positive likelihood ratio, NLR: Negative Likelihood ratio *: Analysis accomplished by using the frequency 4,000 Hz instead of 3,000 Hz Modified Rule 4000 (¥):≥15 dB asymmetry at 4,000 Hz AAO-HNS: American Academy of Otolaryngology-Head and Neck Surgery AMCLASS - Audiogram Classification System - (&): ≥10 dB at any two neighboring frequencies Obholzer (A): ≥15 dB in two neighboring frequencies if better ear averaging 250 to 8,000 Hz is <30 dB. Obholzer (B): ≥20 dB in two neighboring frequencies if better ear averaging 250 to 8,000 Hz is >30 dB. In the analysis of the receiver operating characteristic (ROC) curve (Figure 1), two audiometric patterns had a better performance: a difference ≥20 dB at 4,000 Hz, and a difference ≥20 dB at two adjacent frequencies when the average at 250 to 8,000 Hz was >30 dB in the better ear. The first pattern showed greater sensitivity and better specificity than the other audiometric patterns (sensitivity: 77.78%, specificity: 30.61%, PPV: 9.33%, NPV:93.75%); on the other hand, with greater specificity, there was a loss in sensitivity (sensitivity: 55.56%, specificity: 68.37%, PPV: 8.41%, NPV: 94.37%), respectively. Area Under the Curve (AUC) was 0.542 for the first audiometric pattern (4000 Hz rule) and 0.620 for the second audiometric pattern (Obholzer B).
Figure 1

Receiver operating characteristic (ROC) according to the different definitions of asymmetric hearing loss

In summary, the pattern that showed the best result -as a screening test- was the 4,000 Hz rule, with a sensitivity of 77.78%, specificity of 30.61%, PPV of 9.33%, NPV of 93.75%, and accuracy of 34.58%.

Discussion

In our study, no significant difference in demographic characteristics or audiometric patterns was found in patients with and without VS. This study represents a cross-sectional and multicenter study of asymmetrical hearing loss patients. There are multiple definitions of asymmetrical hearing loss to date (Table 5). Only nine patients with VS were included in this study; however, this corresponds to the usual prevalence of an asymmetric hearing loss population.
Table 5

Asymmetrical protocol parameters described in the literature

AAO-HNS: American Academy of Otolaryngology-Head and Neck Surgery, AMCLASS: recommended asymmetry cutoff, dB: decibels, Hz: Hertz, S: Sensitivity, SPE: Specificity.

                   

Asymmetrical parametersSSpeAuthor
≥20 dB at any single frequency between 500 and 4,000 Hz88%31%UK Department of health [2,3]
≥20 dB at any 2 neighboring frequencies90%39%Sunderland [2,4]
≥15 dB between ears averaging 500 to 3,000 Hz90%57%AAO-HNS [2]
≥15 dB between ears averaging  500 to 8,000 Hz61%62%Oxford [4,6]
≥15 dB between ears averaging 1,000 to 8,000 Hz89%43%Seattle [2]
≥15 dB at any single frequency between 500 and 4,000 Hz83%52%Nashville [4,8]
≥10 dB at any 2 neighboring frequencies or ≥15 dB at any single frequency82%44%AMCLASS [4,9]
≥15 dB asymmetry at 3,000 Hz73%76%Rule 3000 [4,10]
≥20 dB asymmetry at 4,000 Hz87%62%Rule 4000 [4,11]
≥15 dB at any 2 or more neighboring frequencies83%48%Cueva [4,12]
≥10 dB between ears averaging 1,000 to 8,000 Hz82%44%Mangham [4,13]
≥20 dB between ears averaging 1,000 to 8,000 Hz91%66%Schlauch & Levine [4,11]
≥15 dB between ears averaging 250 to 8,000 Hz85%60%Sheppard [4,14]
≥15 dB in 2 neighboring frequencies if better ear averaging 250 to 8,000 Hz is <30 dB or ≥20 dB in 2 neighboring frequencies if better ear averaging 250 to 8,000 Hz is >30 dB91%39%Obholzer [2,15]

Asymmetrical protocol parameters described in the literature

AAO-HNS: American Academy of Otolaryngology-Head and Neck Surgery, AMCLASS: recommended asymmetry cutoff, dB: decibels, Hz: Hertz, S: Sensitivity, SPE: Specificity. According to our results, the clinical characteristics (type of hearing loss, tinnitus, instability, family history, headache, otoscopy or facial mobility) did not allow us to identify patients with VS. Tinnitus had a similar prevalence in both groups (p=0.322), interestingly, patients with VS presented with only unilateral tinnitus. Several studies have emphasized the importance of unilateral tinnitus for the diagnosis of retrocochlear lesions [23]. In contrast, Saliba et al. did not find tinnitus to be significantly related to VS [10]. Audiometry is considered a simple, economic, and easily available test without adverse effects, allowing us to consider it as an optimal screening test. This study had the aim to test all available definitions of asymmetric hearing loss in the literature, therefore, asymmetry ≥15 dB at any frequency was considered as an inclusion criterion; this definition could encompass all of the other definitions of asymmetric hearing loss. This definition has also been used as an inclusion criterion in previous studies [10,24]. High-frequency hearing loss could be the first diagnosis of a retrocochlear lesion, as corroborated by various studies [22-24]. Unfortunately, there are a number of other pathologies that may produce high-frequency hearing loss such as the aging ear and acoustic trauma. The sensitivity, specificity, PPV and NPV of each of the definitions and frequencies were calculated, with the best performance found for asymmetry ≥20 dB at the 4,000 Hz frequency, which was better than the other definitions proposed in the literature. Regarding the diagnostic algorithms of VSs, Saliba et al. [10] proposed a diagnostic approach consisting of performing MRI only in patients with asymmetric hearing loss of ≥15 dB at 3,000 Hz, known as the “3000 Hz rule,” with approximately 70% sensitivity and 70% specificity. In our center, unfortunately, this frequency is not measured routinely; however, the closest frequency is - 4,000 Hz - this frequency had higher parameters in ≥20 dB of difference between ears. This frequency (4,000 Hz) could be later named as the “4000 Hz rule” since it showed the best parameters as a diagnostic test (sensitivity: 77.78%, specificity: 30.61%, PPV: 9.33%, NPV: 93.75%). A study conducted in Denmark by Gimsing [24] calculated the sensitivity and specificity of all of the definitions of asymmetry in the literature in a population of 199 patients with schwannoma and 225 patients without schwannoma who had undergone an MRI. They found a sensitivity of 73% to 100% with an average specificity of 50%. Similarly, Obholzer et al. [15] performed an analysis of the sensitivity and specificity of each of the different audiometric criteria of asymmetric hearing loss for the diagnosis of retrocochlear lesions, using MRI as a gold standard. The authors concluded that asymmetric hearing loss of two adjacent frequencies >15 dB if the threshold of the better ear is ≤30 dB or asymmetry of 20 dB if the threshold of the better ear is >30 dB, with a sensitivity and specificity of 91% and 39%, respectively. This finding contrasted with the low sensitivity and specificity of 67% and 56%, respectively, found in our study. During our analysis, it was found that asymmetry of ≥20 dB at two adjacent frequencies when the average at 250 to 8,000 Hz was >30 dB in the better ear, showed the highest specificity of all (68.37%); however, the sensitivity was very low (55.56%), so it could not be considered an ideal screening test for VS. This high specificity has been previously published by other authors [25]. Unfortunately, in a screening test, the sensitivity needs to be prioritized. Our results had low sensitivity and specificity in all the parameters studied. It is necessary to emphasize that the most relevant studies comparing the audiometry of patients with and without tumors were performed retrospectively based on MRI. These former studies were not prospective studies but case-control studies. This fact explains the paradoxical normal hearing in their control groups [10,23]. In contrast, our study relies on asymmetrical hearing loss as inclusion criteria and also represents one of the few cross-sectional studies available to date. Unlike what has been described in another study that included asymmetry ≥15 dB in its logistic regression model as an independent predictor variable of the presence of VS [23], in our study, we analyzed the audiometry based on the definitions of asymmetric hearing described in the literature, and none of these definitions was independently related to increased risk of presenting with VS. Strengths of this study rely on the multiple analysis of all the asymmetric hearing loss definitions available in the literature; additionally, we studied each frequency and its respective asymmetries. Since the audiometry did not show an adequate performance as a screening test, it relies on us, the clinicians, to indicate the MRI in any case of suspicion; nevertheless, the best definition in this study was the Rule of 4000. It is important to consider these results since an undiagnosed schwannoma misses the possibility of being submitted on time to a procedure (radio-neurosurgery or neurosurgery) to preserve hearing and increase the quality of life of our patients. The most recent study on MRI and asymmetric hearing loss, included 1059 patients, among those patients, there were only 16 patients with VS. The authors performed equally an analysis with the different definitions of asymmetric hearing loss. Overall, their results are similar to ours, but our sensitivity is lower since none of the definitions reached 100%. Additionally, the proportion of VS patients in Bhargava study is much lower than ours; which is explained due to the reduced incidence of the disease. Cross-sectional studies tend to have scant VS patients. The main limitation of this study is the low number of patients with VS; nonetheless, the occurrence of VS is 2%-8% [15] in patients with asymmetric hearing loss in a population-based study. Our study was performed on consecutive patients, so our numbers could portray the day-to-day cases of an otolaryngologic clinic. Since this is a study of only two hospitals, these data could not be extrapolated to a nationwide external validity sample; nevertheless, our numbers are similar to previously published data. More studies are needed to corroborate our results. Till today, the MRI is the gold standard in the study of asymmetric hearing loss.

Conclusions

Patients seen at a neurotology and otolaryngology center with asymmetric hearing loss could not be differentiated from patients with retrocochlear lesions based on audiometry alone. No significant difference in demographic characteristics or audiometric patterns was found in patients with and without VS. Clinical suspicion is recommended if there is asymmetry of at least 20 dB in the 4,000 Hz frequency. Asymmetrical hearing loss must be studied with MRI. More studies are needed to corroborate our results.
  25 in total

1.  Analysis of the efficiency of retrocochlear screening.

Authors:  J P Kotlarz; T L Eby; T E Borton
Journal:  Laryngoscope       Date:  1992-10       Impact factor: 3.325

2.  What is the real incidence of vestibular schwannoma?

Authors:  Mirko Tos; Sven-Eric Stangerup; Per Cayé-Thomasen; Tina Tos; Jens Thomsen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-02

3.  Three-year ear, nose, and throat cross-sectional analysis of audiometric protocols for magnetic resonance imaging screening of acoustic tumors.

Authors:  Teddy Caramoan Cheng; Michael J Wareing
Journal:  Otolaryngol Head Neck Surg       Date:  2011-11-10       Impact factor: 3.497

4.  Incidence of vestibular schwannomas in the United States.

Authors:  Varun R Kshettry; Jason K Hsieh; Quinn T Ostrom; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2015-05-30       Impact factor: 4.130

5.  Auditory brainstem response versus magnetic resonance imaging for the evaluation of asymmetric sensorineural hearing loss.

Authors:  Roberto A Cueva
Journal:  Laryngoscope       Date:  2004-10       Impact factor: 3.325

6.  Asymmetric hearing loss: rule 3,000 for screening vestibular schwannoma.

Authors:  Issam Saliba; Geneviève Martineau; Miguel Chagnon
Journal:  Otol Neurotol       Date:  2009-06       Impact factor: 2.311

7.  Screening patients with sensorineural hearing loss for vestibular schwannoma using a Bayesian classifier.

Authors:  S A R Nouraei; Q J M Huys; P Chatrath; J Powles; J P Harcourt
Journal:  Clin Otolaryngol       Date:  2007-08       Impact factor: 2.597

8.  Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

9.  Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

Review 10.  Biomarkers in Vestibular Schwannoma-Associated Hearing Loss.

Authors:  Luis Lassaletta; Miryam Calvino; Jose Manuel Morales-Puebla; Pablo Lapunzina; Lourdes Rodriguez-de la Rosa; Isabel Varela-Nieto; Victor Martinez-Glez
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.